Immix Biopharma Inc reports results for the quarter ended in December - Earnings Summary

Retrieved on: 2024-04-02 16:30:02

Tags for this article:

Click the tags to see associated articles and topics

Immix Biopharma Inc reports results for the quarter ended in December - Earnings Summary. View article details on hiswai:

Excerpt

FORECAST CHANGESRECOMMENDATIONSWall Street's median 12-month price target for Immix Biopharma Inc is $14.00 This summary was machine generated ...

Article found on: www.tradingview.com